Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 2
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
Marion Pons, Stylianos Georgiadis, Mikkel Østergaard, Zohra Faizy Ahmadzay, Bente Glintborg, Jette Heberg, Sara Nysom Christensen, Simon Horskjær Rasmussen, Anne Gitte Loft, Isabel Castrejón, Žiga Rotar, Katja Perdan-Pirkmajer
Izvirni znanstveni članek
Oznake: bDMARD;epidemiology;spondyloarthritis;
Objectives: In axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) patients initiating secukinumab, we aimed to assess retention rates and proportions of patients achieving remission and low disease activity (LDA), according to disease activity measures and patient-reported outcomes at 24 ...
Leto: 2025 Vir: Medicinska fakulteta (UL MF)
Predictors of secukinumab treatment response and continuation in axial spondyloarthritis
Marion Pons, Marion Pons, Stylianos Georgiadis, Merete Lund Hetland, Zohra Faizy Ahmadzay, Simon Horskjær Rasmussen, Sara Nysom Christensen, Daniela Di Giuseppe, Johan Karlsson Wallman, Karel Pavelka, Jakub Závada, Katja Perdan-Pirkmajer, Žiga Rotar
Izvirni znanstveni članek
Oznake: spondyloarthritis;epidemiology;biologic therapy;
Objective: In patients with axial spondyloarthritis (axSpA) initiating secukinumab, we aimed to identify baseline (treatment start) predictors of achieving low disease activity (LDA) after 6 months, as measured by Axial Spondyloarthritis Disease Activity Score using C-reactive protein (ASDAS-CRP) an ...
Leto: 2025 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 2
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: